Controlling hospital MRSA
- PMID: 27873606
- PMCID: PMC7104055
- DOI: 10.1016/j.jgar.2013.01.006
Controlling hospital MRSA
Abstract
Recent evidence from publications describing the success of interventions to control hospital meticillin-resistant Staphylococcus aureus (MRSA), often in the endemic setting, is reviewed. Overall, there is cautious ground for optimism that MRSA can be controlled in a cost-effective manner by employing a bundle approach, the mainstay of which is widespread admission screening to inform patient-specific control measures.
Keywords: Bundles; Chlorhexidine; Decolonisation; Healthcare-associated infection; MRSA; Screening.
Copyright © 2013 International Society for Chemotherapy of Infection and Cancer. Published by Elsevier Ltd. All rights reserved.
References
-
- Carbonne A., Arnaud I., Maugat S., Marty N., Dumartin C., Bertrand X. National multidrug-resistant bacteria (MDRB) surveillance in France through the RAISIN network: a 9 year experience. Journal of Antimicrobial Chemotherapy. 2012;(November) doi: 10.1093/jac/dks464. [Epub ahead of print] - DOI - PubMed
-
- Office for National Statistics. Deaths involving MRSA: England and Wales, 2006 to 2010. http://www.ons.gov.uk/ons/rel/subnational-health2/deaths-involving-mrsa/... [accessed 12 December 2012].
-
- Gould I.M. Antibiotic policies to control hospital-acquired infection. Journal of Antimicrobial Chemotherapy. 2008;61:763–765. - PubMed
-
- Knight G.M., Budd E.L., Whitney L., Thornley A., Al-Ghusein H., Planche T. Shift in dominant hospital-associated methicillin-resistant Staphylococcus aureus (HA-MRSA) clones over time. Journal of Antimicrobial Chemotherapy. 2009;67:2514–2522. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
